A patient with a 6q22.1 deletion and a phenotype of non-progressive early-onset generalized epilepsy with tremor

•Generalized epilepsy with tremor phenotype ss a clinical marker of 6q22.1 microdeletion.•Deep brain stimulation may be applicable choince for intractable myoclonic tremor.•Over activation of basal ganglia may be related to this patient's symptoms. We report a patient with a 6q22.1 deletion, wh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Epilepsy & behavior reports 2021-01, Vol.15, p.100405-100405, Article 100405
Hauptverfasser: Haginoya, Kazuhiro, Sekiguchi, Futoshi, Munakata, Mitsutoshi, Yokoyama, Hiroyuki, Hino-Fukuyo, Naomi, Uematsu, Mitsugu, Jin, Kazutaka, Nagamatsu, Kenichi, Ando, Tadashi, Miyake, Noriko, Matsumoto, Naomichi, Kure, Shigeo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Generalized epilepsy with tremor phenotype ss a clinical marker of 6q22.1 microdeletion.•Deep brain stimulation may be applicable choince for intractable myoclonic tremor.•Over activation of basal ganglia may be related to this patient's symptoms. We report a patient with a 6q22.1 deletion, who presented with a rare syndrome of generalized epilepsy, myoclonic tremor, and intellectual disability. There was no clinical progression after follow-up for more than 10 years. Our report presents the genetic basis for a phenotype involving a non-progressive generalized epilepsy with tremor. The efficacy of valproic acid for seizure control and the partial efficacy of deep brain stimulation with propranolol for myoclonic tremor is detailed.
ISSN:2589-9864
2589-9864
DOI:10.1016/j.ebr.2020.100405